These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15114030)

  • 1. Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?
    Tsirpanlis G
    Kidney Blood Press Res; 2004; 27(3):134-42. PubMed ID: 15114030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
    Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.
    Liu C; Waters DD
    Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of infection in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):671-6. PubMed ID: 15810509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chlamydia pneumoniae antibodies and other atherosclerosis risk factors in haemodialysed patients. Preliminary report].
    Prokopiuk M; Wierzbicki P; Kade G; Dudko S; Wańkowicz Z
    Pol Merkur Lekarski; 2002 Nov; 13(77):380-3. PubMed ID: 12621753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae and atherosclerosis.
    Hoymans VY; Bosmans JM; Ieven M; Vrints CJ
    Acta Chir Belg; 2002 Oct; 102(5):317-22. PubMed ID: 12471763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure.
    Song H; Tasaki H; Yashiro A; Okazaki M; Ioka T; Taniguchi H; Nakashima Y
    Clin Nephrol; 2001 Nov; 56(5):346-52. PubMed ID: 11758004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of Chlamydia pneumoniae and atherosclerosis.
    Lindholt JS; Fasting H; Henneberg EW; Ostergaard L
    Eur J Vasc Endovasc Surg; 1999 Apr; 17(4):283-9. PubMed ID: 10204048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.